| Bioactivity | Tibric acid (CP 18524) has similar effects to those of hypolipidemic agents. Tibric acid has orally active triglyceride-lowering effects. Tibric acid can be used for research of hypertriglyceridemia[1][2]. |
| In Vivo | Tibric Acid (13-125 mg/kg/d，口服，每日一次，持续 1 周) 可降低大鼠血清胆固醇和甘油三酯水平[1]。 Animal Model: |
| Name | Tibric acid |
| CAS | 37087-94-8 |
| Formula | C14H18ClNO4S |
| Molar Mass | 331.82 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bielmann P, et al. Dose-response to tibric acid: a new hypolipidemic drug in type IV hyperlipoproteinemia. Clin Pharmacol Ther. 1975 May;17(5):606-11. [2]. Cayen MN, et al. Effect of tibric acid on hepatic cholesterol synthesis in rats. Lipids. 1977 Aug;12(8):684-8. |
Tibric acid
CAS: 37087-94-8 F: C14H18ClNO4S W: 331.82
Tibric acid (CP 18524) has similar effects to those of hypolipidemic agents. Tibric acid has orally active triglyceride-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.